Healthy potentially undervalued

Results

35

2 new

Companies which are potentially undervalued and in an acceptable financial position.

35 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	CPHN	CHF 57.00	0.7%	-25.0%	CHF 339.3m	CHF 89.73	14.6	11.7%	3.5%	Materials
	ZEHN	CHF 61.30	2.5%	-13.8%	CHF 679.1m	CHF 85.59	15.9	16.1%	2.3%	Capital Goods
	KOMN	CHF 46.70	6.5%	-54.7%	CHF 234.5m	CHF 62.28	0.4	75.3%	0%	Capital Goods
	BCHN	CHF 467.50	6.5%	-31.4%	CHF 1.6b	CHF 604.33	14.3	1.6%	3.9%	Capital Goods
	ROP	CHF 330.20	-1.4%	28.9%	CHF 260.9b	CHF 359.22	20.4	8.5%	3.0%	Pharmaceuticals & Biotech
	AMS	CHF 18.69	5.2%	57.5%	CHF 1.9b	CHF 15.96	0.6	62.6%	0%	Semiconductors
	SREN	CHF 134.30	1.2%	-5.2%	CHF 40.0b	CHF 128.48	10.0	-1.8%	4.8%	Insurance
	SUN	CHF 141.60	3.6%	-2.7%	CHF 4.8b	CHF 184.60	16.3	9.9%	3.4%	Capital Goods
	IMPN New	CHF 68.00	-4.2%	31.0%	CHF 1.2b	CHF 86.00	15.0	12.3%	2.1%	Capital Goods
	RSGN	CHF 22.68	-6.6%	-24.9%	CHF 801.0m	CHF 27.80	14.5	6.6%	2.2%	Capital Goods
	SOON	CHF 207.20	3.1%	-9.7%	CHF 12.1b	CHF 218.78	22.9	10.2%	2.3%	Healthcare
	LOGN	CHF 80.88	3.6%	7.3%	CHF 11.8b	CHF 91.83	20.1	5.6%	1.7%	Tech
	FORN	CHF 746.00	4.2%	-14.7%	CHF 1.0b	CHF 893.33	15.4	11.8%	3.4%	Capital Goods
	AMRZ	CHF 40.72	1.6%	0.9%	CHF 22.4b	CHF 50.32	24.0	15.1%	0.9%	Materials
	RIEN	CHF 3.19	6.7%	-95.3%	CHF 418.1m	CHF 3.49	0.6	82.8%	0%	Capital Goods
	ADEN	CHF 17.77	9.3%	-29.9%	CHF 3.1b	CHF 21.06	10.9	13.4%	5.6%	Commercial Services
	BSLN	CHF 52.40	-3.5%	-3.9%	CHF 644.6m	CHF 86.88	16.1	7.8%	n/a	Pharmaceuticals & Biotech
	CICN	CHF 113.80	1.4%	-38.8%	CHF 495.5m	CHF 170.30	29.6	31.8%	0%	Tech
	CLN	CHF 7.83	8.1%	-8.4%	CHF 2.6b	CHF 8.55	0.7	46.1%	5.4%	Materials
	LAND	CHF 41.75	2.1%	-32.3%	CHF 1.2b	CHF 62.48	37.6	32.8%	2.9%	Tech
	AUTN	CHF 114.00	2.2%	-21.4%	CHF 649.0m	CHF 142.24	11.0	8.8%	2.8%	Automobiles
	BYS	CHF 136.40	-1.9%	-65.1%	CHF 276.2m	CHF 192.04	0.5	66.1%	2.9%	Capital Goods
	INRN	CHF 1,322.00	3.4%	-42.0%	CHF 1.1b	CHF 2,257.14	19.7	10.9%	2.4%	Capital Goods
	TECN	CHF 183.60	9.4%	11.1%	CHF 2.3b	CHF 175.48	2.6	48.0%	1.6%	Pharmaceuticals & Biotech

Page 1 of 1